196 related articles for article (PubMed ID: 477719)
1. 3,4-Dihydroxyphenylacetic acid and homovanillic acid in rat plasma: possible indicators of central dopaminergic activity.
Bacopoulos NG; Hattox SE; Roth RH
Eur J Pharmacol; 1979 Jun; 56(3):225-36. PubMed ID: 477719
[TBL] [Abstract][Full Text] [Related]
2. Effect of probenecid on endogenous and exogenous 3,4-dihydroxyphenylacetic acid and homovanillic acid in the rat brain.
Broch OJ
Eur J Pharmacol; 1976 Sep; 39(1):33-40. PubMed ID: 964303
[TBL] [Abstract][Full Text] [Related]
3. Studies on the central or peripheral origin of free and sulfated 3,4-dihydroxyphenylacetic acid in rat plasma.
Boudet C; Peyrin L; Tavitian E; Claustre J; Favre R
Eur J Pharmacol; 1984 Aug; 103(3-4):295-301. PubMed ID: 6149138
[TBL] [Abstract][Full Text] [Related]
4. Striatal and mesolimbic dopaminergic contribution to 3,4-dihydroxyphenylacetic acid sulfate in rat plasma.
Boudet C; Simon H; Cottet-Emard JM; Dalmaz Y; Peyrin L
Eur J Pharmacol; 1986 Feb; 121(1):113-8. PubMed ID: 3082654
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the synthesis and metabolism of striatal dopamine after disruption of nerve conduction in the medial forebrain bundle.
Commissiong JW; Slimovitch C; Toffano G
Br J Pharmacol; 1990 Apr; 99(4):741-9. PubMed ID: 2361171
[TBL] [Abstract][Full Text] [Related]
6. Turnover of acid dopamine metabolites in striatal and mesolimbic tissue of the rat brain.
Westerink BH; Korf J
Eur J Pharmacol; 1976 Jun; 37(2):249-55. PubMed ID: 954808
[TBL] [Abstract][Full Text] [Related]
7. Comparison of effects of drugs on dopamine metabolism in the substantia nigra and the corpus striatum of rat brain.
Westerink BH; Korf J
Eur J Pharmacol; 1976 Nov; 40(1):131-6. PubMed ID: 991922
[TBL] [Abstract][Full Text] [Related]
8. Effects of nigrostriatal pathway stimulation and tropolone on plasma concentration of 3,4-dihydroxyphenylacetic acid.
Bacopoulos NG; Hattox SE; Roth RH
Biochem Pharmacol; 1977 Nov; 26(22):2197-9. PubMed ID: 588304
[No Abstract] [Full Text] [Related]
9. Interrelationships between plasma homovanillic acid and indices of dopamine turnover in multiple brain areas during haloperidol and saline administration.
Csernansky JG; Barnes DE; Bellows EP; Lombrozo L
Life Sci; 1990; 46(10):707-13. PubMed ID: 2314192
[TBL] [Abstract][Full Text] [Related]
10. Brain contribution to the haloperidol-induced increase in plasma homovanillic acid.
Kendler KS; Heninger GR; Roth RH
Eur J Pharmacol; 1981 May; 71(2-3):321-6. PubMed ID: 7250191
[TBL] [Abstract][Full Text] [Related]
11. Apomorphine-haloperidol interactions: different types of antagonism in cortical and subcortical brain regions.
Bacopoulos NG; Roth RH
Brain Res; 1981 Feb; 205(2):313-9. PubMed ID: 7470869
[TBL] [Abstract][Full Text] [Related]
12. Regional rat brain levels of 3,4-dihydroxyphenylacetic acid and homovanillic acid: concurrent fluorometric measurement and influence of drugs.
Westerink BH; Korf J
Eur J Pharmacol; 1976 Aug; 38(2):281-91. PubMed ID: 954842
[TBL] [Abstract][Full Text] [Related]
13. Effect of various centrally acting drugs on the efflux of dopamine metabolites from the rat brain.
Westerink BH; Kikkert RJ
J Neurochem; 1986 Apr; 46(4):1145-52. PubMed ID: 3950621
[TBL] [Abstract][Full Text] [Related]
14. Free and conjugated 3,4-dihydroxyphenylacetic acid and homovanillic acid in brain dopaminergic areas at basal state and after pipotiazine activation.
Tavitian E; Peyrin L; Dalmaz Y; Favre R; De Haut M; Cottet-Emard JM
J Neural Transm; 1986; 65(3-4):261-75. PubMed ID: 2872271
[TBL] [Abstract][Full Text] [Related]
15. Developmental change in striatal concentration of homovanillic acid and 3,4-dihydroxyphenylacetic acid in response to apomorphine and haloperidol treatment.
Nomura Y; Komori T; Okuda S; Segawa T
Arch Int Pharmacodyn Ther; 1979 Jan; 237(1):25-30. PubMed ID: 485682
[TBL] [Abstract][Full Text] [Related]
16. Determination of dopamine, homovanillic acid and 3,4-dihydroxyphenylacetic acid in rat brain striatum by high-performance liquid chromatography with electrochemical detection.
Saraswat LD; Holdiness MR; Justice JB; Salamone JD; Neill DB
J Chromatogr; 1981 Mar; 222(3):353-62. PubMed ID: 7228945
[TBL] [Abstract][Full Text] [Related]
17. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid.
Steranka LR
Brain Res; 1982 Feb; 234(1):123-36. PubMed ID: 7059818
[TBL] [Abstract][Full Text] [Related]
18. Increased transport of 3,4-dihydroxyphenylacetic acid from brain during performance of operant behavior in the rat.
Heffner TG; Vosmer G; Seiden LS
Brain Res; 1984 Feb; 293(1):85-91. PubMed ID: 6200185
[TBL] [Abstract][Full Text] [Related]
19. Effects of neurotransmitters or drugs on the in vivo release of dopamine and its metabolites.
Kito S; Shimoyama M; Arakawa R
Jpn J Pharmacol; 1986 Jan; 40(1):57-67. PubMed ID: 2870204
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of haloperidol-induced increase in rat striatal or mesolimbic 3,4-dihydroxyphenylacetic acid and homovanillic acid by pretreatment with chronic methamphetamine.
Toru M; Mataga N; Takashima M; Nishikawa T
Psychopharmacology (Berl); 1981; 74(4):316-20. PubMed ID: 6794073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
